TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. RSV DIAGNOSTICS MARKET, BY TEST TYPE (USD BILLION)
6.1. Molecular Tests
6.2. Antigen Tests
6.3. Serological Tests
6.4. Virus Culture
7. RSV DIAGNOSTICS MARKET, BY END USER (USD BILLION)
7.1. Hospitals
7.2. Diagnostic Laboratories
7.3. Research Institutions
8. RSV DIAGNOSTICS MARKET, BY SAMPLE TYPE (USD BILLION)
8.1. Nasal Swabs
8.2. Throat Swabs
8.3. Bronchoalveolar Lavage
9. RSV DIAGNOSTICS MARKET, BY TECHNIQUE (USD BILLION)
9.1. Polymerase Chain Reaction
9.2. Enzyme-Linked Immunosorbent Assay
9.3. Immunofluorescence Assay
10. RSV DIAGNOSTICS MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the RSV Diagnostics Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the RSV Diagnostics Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. Siemens Healthineers
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. Fujifilm
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. AAccucare
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. Thermo Fisher Scientific
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. GenMark Diagnostics
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. bioMérieux
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. Luminex
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. Quidel Corporation
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. Abbott Laboratories
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. BD
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. PerkinElmer
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. Roche
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. Cepheid
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. Hologic
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
12.15. NURX Medical
12.15.1. Financial Overview
12.15.2. Products Offered
12.15.3. Key Developments
12.15.4. SWOT Analysis
12.15.5. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 6. NORTH AMERICA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 7. US RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 8. US RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 9. US RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 10. US RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 11. US RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 12. CANADA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 13. CANADA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 14. CANADA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 15. CANADA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 16. CANADA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 17. EUROPE RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 18. EUROPE RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 19. EUROPE RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 20. EUROPE RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 21. EUROPE RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 22. GERMANY RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 23. GERMANY RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 24. GERMANY RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 25. GERMANY RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 26. GERMANY RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 27. UK RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 28. UK RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 29. UK RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 30. UK RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 31. UK RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 32. FRANCE RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 33. FRANCE RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 34. FRANCE RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 35. FRANCE RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 36. FRANCE RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 37. RUSSIA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 38. RUSSIA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 39. RUSSIA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 40. RUSSIA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 41. RUSSIA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 42. ITALY RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 43. ITALY RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 44. ITALY RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 45. ITALY RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 46. ITALY RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 47. SPAIN RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 48. SPAIN RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 49. SPAIN RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 50. SPAIN RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 51. SPAIN RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 52. REST OF EUROPE RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 53. REST OF EUROPE RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 54. REST OF EUROPE RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 55. REST OF EUROPE RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 56. REST OF EUROPE RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 57. APAC RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 58. APAC RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 59. APAC RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 60. APAC RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 61. APAC RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 62. CHINA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 63. CHINA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 64. CHINA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 65. CHINA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 66. CHINA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 67. INDIA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 68. INDIA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 69. INDIA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 70. INDIA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 71. INDIA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 72. JAPAN RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 73. JAPAN RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 74. JAPAN RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 75. JAPAN RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 76. JAPAN RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 77. SOUTH KOREA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 78. SOUTH KOREA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 79. SOUTH KOREA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 80. SOUTH KOREA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 81. SOUTH KOREA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 82. MALAYSIA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 83. MALAYSIA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 84. MALAYSIA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 85. MALAYSIA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 86. MALAYSIA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 87. THAILAND RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 88. THAILAND RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 89. THAILAND RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 90. THAILAND RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 91. THAILAND RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 92. INDONESIA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 93. INDONESIA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 94. INDONESIA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 95. INDONESIA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 96. INDONESIA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 97. REST OF APAC RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 98. REST OF APAC RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 99. REST OF APAC RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 100. REST OF APAC RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 101. REST OF APAC RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 102. SOUTH AMERICA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 103. SOUTH AMERICA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 104. SOUTH AMERICA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 105. SOUTH AMERICA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 106. SOUTH AMERICA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 107. BRAZIL RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 108. BRAZIL RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 109. BRAZIL RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 110. BRAZIL RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 111. BRAZIL RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 112. MEXICO RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 113. MEXICO RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 114. MEXICO RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 115. MEXICO RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 116. MEXICO RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 117. ARGENTINA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 118. ARGENTINA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 119. ARGENTINA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 120. ARGENTINA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 121. ARGENTINA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 122. REST OF SOUTH AMERICA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 123. REST OF SOUTH AMERICA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 124. REST OF SOUTH AMERICA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 125. REST OF SOUTH AMERICA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 126. REST OF SOUTH AMERICA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 127. MEA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 128. MEA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 129. MEA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 130. MEA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 131. MEA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 132. GCC COUNTRIES RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 133. GCC COUNTRIES RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 134. GCC COUNTRIES RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 135. GCC COUNTRIES RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 136. GCC COUNTRIES RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 137. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 138. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 139. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 140. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 141. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 142. REST OF MEA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2032 (USD BILLIONS)
TABLE 143. REST OF MEA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 144. REST OF MEA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY SAMPLE TYPE, 2019-2032 (USD BILLIONS)
TABLE 145. REST OF MEA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2032 (USD BILLIONS)
TABLE 146. REST OF MEA RSV DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA RSV DIAGNOSTICS MARKET ANALYSIS
FIGURE 3. US RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 4. US RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 5. US RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 6. US RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 7. US RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 8. CANADA RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 9. CANADA RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 10. CANADA RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 11. CANADA RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 12. CANADA RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 13. EUROPE RSV DIAGNOSTICS MARKET ANALYSIS
FIGURE 14. GERMANY RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 15. GERMANY RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 16. GERMANY RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 17. GERMANY RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 18. GERMANY RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 19. UK RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 20. UK RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 21. UK RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 22. UK RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 23. UK RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 24. FRANCE RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 25. FRANCE RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 26. FRANCE RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 27. FRANCE RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 28. FRANCE RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 29. RUSSIA RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 30. RUSSIA RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 31. RUSSIA RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 32. RUSSIA RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 33. RUSSIA RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 34. ITALY RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 35. ITALY RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 36. ITALY RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 37. ITALY RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 38. ITALY RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 39. SPAIN RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 40. SPAIN RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 41. SPAIN RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 42. SPAIN RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 43. SPAIN RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 44. REST OF EUROPE RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 45. REST OF EUROPE RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 46. REST OF EUROPE RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 47. REST OF EUROPE RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 48. REST OF EUROPE RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 49. APAC RSV DIAGNOSTICS MARKET ANALYSIS
FIGURE 50. CHINA RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 51. CHINA RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 52. CHINA RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 53. CHINA RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 54. CHINA RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 55. INDIA RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 56. INDIA RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 57. INDIA RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 58. INDIA RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 59. INDIA RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 60. JAPAN RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 61. JAPAN RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 62. JAPAN RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 63. JAPAN RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 64. JAPAN RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 65. SOUTH KOREA RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 66. SOUTH KOREA RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 67. SOUTH KOREA RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 68. SOUTH KOREA RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 69. SOUTH KOREA RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 70. MALAYSIA RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 71. MALAYSIA RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 72. MALAYSIA RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 73. MALAYSIA RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 74. MALAYSIA RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 75. THAILAND RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 76. THAILAND RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 77. THAILAND RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 78. THAILAND RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 79. THAILAND RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 80. INDONESIA RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 81. INDONESIA RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 82. INDONESIA RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 83. INDONESIA RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 84. INDONESIA RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 85. REST OF APAC RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 86. REST OF APAC RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 87. REST OF APAC RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 88. REST OF APAC RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 89. REST OF APAC RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 90. SOUTH AMERICA RSV DIAGNOSTICS MARKET ANALYSIS
FIGURE 91. BRAZIL RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 92. BRAZIL RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 93. BRAZIL RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 94. BRAZIL RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 95. BRAZIL RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 96. MEXICO RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 97. MEXICO RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 98. MEXICO RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 99. MEXICO RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 100. MEXICO RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 101. ARGENTINA RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 102. ARGENTINA RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 103. ARGENTINA RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 104. ARGENTINA RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 105. ARGENTINA RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 106. REST OF SOUTH AMERICA RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 107. REST OF SOUTH AMERICA RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 108. REST OF SOUTH AMERICA RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 109. REST OF SOUTH AMERICA RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 110. REST OF SOUTH AMERICA RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 111. MEA RSV DIAGNOSTICS MARKET ANALYSIS
FIGURE 112. GCC COUNTRIES RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 113. GCC COUNTRIES RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 114. GCC COUNTRIES RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 115. GCC COUNTRIES RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 116. GCC COUNTRIES RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 117. SOUTH AFRICA RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 118. SOUTH AFRICA RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 119. SOUTH AFRICA RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 120. SOUTH AFRICA RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 121. SOUTH AFRICA RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 122. REST OF MEA RSV DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE
FIGURE 123. REST OF MEA RSV DIAGNOSTICS MARKET ANALYSIS BY END USER
FIGURE 124. REST OF MEA RSV DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE
FIGURE 125. REST OF MEA RSV DIAGNOSTICS MARKET ANALYSIS BY TECHNIQUE
FIGURE 126. REST OF MEA RSV DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 127. KEY BUYING CRITERIA OF RSV DIAGNOSTICS MARKET
FIGURE 128. RESEARCH PROCESS OF MRFR
FIGURE 129. DRO ANALYSIS OF RSV DIAGNOSTICS MARKET
FIGURE 130. DRIVERS IMPACT ANALYSIS: RSV DIAGNOSTICS MARKET
FIGURE 131. RESTRAINTS IMPACT ANALYSIS: RSV DIAGNOSTICS MARKET
FIGURE 132. SUPPLY / VALUE CHAIN: RSV DIAGNOSTICS MARKET
FIGURE 133. RSV DIAGNOSTICS MARKET, BY TEST TYPE, 2024 (% SHARE)
FIGURE 134. RSV DIAGNOSTICS MARKET, BY TEST TYPE, 2019 TO 2032 (USD Billions)
FIGURE 135. RSV DIAGNOSTICS MARKET, BY END USER, 2024 (% SHARE)
FIGURE 136. RSV DIAGNOSTICS MARKET, BY END USER, 2019 TO 2032 (USD Billions)
FIGURE 137. RSV DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024 (% SHARE)
FIGURE 138. RSV DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019 TO 2032 (USD Billions)
FIGURE 139. RSV DIAGNOSTICS MARKET, BY TECHNIQUE, 2024 (% SHARE)
FIGURE 140. RSV DIAGNOSTICS MARKET, BY TECHNIQUE, 2019 TO 2032 (USD Billions)
FIGURE 141. RSV DIAGNOSTICS MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 142. RSV DIAGNOSTICS MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS
